Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.41 | -$0.40 | -$0.40 |
Q2 2024 | 3 | -$0.27 | -$0.26 | -$0.26 |
Q3 2024 | 1 | -$0.23 | -$0.23 | -$0.23 |
Q4 2024 | 2 | -$0.31 | -$0.27 | -$0.30 |
Q1 2025 | 1 | -$0.39 | -$0.38 | -$0.38 |
Q2 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
Q4 2025 | 1 | -$0.27 | -$0.26 | -$0.26 |
Q1 2026 | 1 | -$0.37 | -$0.36 | -$0.36 |
Q2 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
Q3 2026 | 1 | -$0.15 | -$0.14 | -$0.15 |
Q4 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
OrthoPediatrics Corp. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.18 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.06. The company had revenue of 54.57 M for the quarter and had revenue of 148.73 M for the year. OrthoPediatrics Corp. has generated $-1 earnings per share over the last year ($-0.92 diluted earnings per share) and currently has a price-to-earnings ratio of -18.65. OrthoPediatrics Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.34 | $53.73 M | $54.57 M | ||
08/06/2024 | Q2 2024 | -$0.26 | $52.52 M | $52.80 M | ||
05/07/2024 | Q1 2024 | -$0.34 | $44.69 M | |||
03/08/2024 | Q4 2023 | -$0.29 | $37.61 M | |||
11/07/2023 | Q3 2023 | -$0.20 | $40.37 M | $39.97 M | ||
08/01/2023 | Q2 2023 | -$0.13 | $39.13 M | $39.56 M | ||
05/02/2023 | Q1 2023 | -$0.30 | $31.59 M | |||
03/01/2023 | Q4 2022 | -$0.35 | $30.99 M | |||
11/01/2022 | Q3 2022 | $0.88 | $36.15 M | $34.95 M | ||
08/04/2022 | Q2 2022 | -$0.02 | $32.40 M | $32.93 M | ||
05/05/2022 | Q1 2022 | -$0.47 | $23.42 M | |||
03/03/2022 | Q4 2021 | $0.00 | $24.81 M | |||
11/04/2021 | Q3 2021 | -$0.11 | $26.28 M | $25.08 M | ||
08/05/2021 | Q2 2021 | -$0.19 | $24.25 M | $26.70 M | ||
05/06/2021 | Q1 2021 | -$0.54 | $21.46 M | |||
03/11/2021 | Q4 2020 | -$0.73 | $18.92 M | |||
11/05/2020 | Q3 2020 | -$0.24 | $19.97 M | $22.21 M | ||
08/06/2020 | Q2 2020 | -$0.54 | $11.43 M | $13.59 M | ||
05/06/2020 | Q1 2020 | -$0.30 | $16.36 M | |||
03/05/2020 | Q4 2019 | -$0.36 | $18.95 M |
OrthoPediatrics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
The conference call for OrthoPediatrics Corp.'s latest earnings report can be listened to online.
The conference call transcript for OrthoPediatrics Corp.'s latest earnings report can be read online.
OrthoPediatrics Corp. (:KIDS) has a recorded annual revenue of $148.73 M.
OrthoPediatrics Corp. (:KIDS) has a recorded net income of $148.73 M. OrthoPediatrics Corp. has generated $-0.92 earnings per share over the last four quarters.
OrthoPediatrics Corp. (:KIDS) has a price-to-earnings ratio of -18.65 and price/earnings-to-growth ratio is 1.45.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED